2025/09/01 by Helens, Unknown
paper · doi:10.15161/oar.it/qbph3-vyz72
Preformulation is a key stage of drug development, We have professional pharmaceutical scientists who can conduct research from routine to highly complex and challenging characterization. \n\n Physical Characteristics Test Capability\n\n XRPD Characterization\n\n Method development (identification, limit testing, etc.) of the crystalline and amorphous ratios of API and excipients depends on each composition.\n\n Particle Size Determination\n\n \n\t The particle size distribution of multiple technologies covers a wide range of size intervals.\n\t Capable of analyzing wet emulsions, suspensions and bulk dry dispersions.\n\t Identify different sample types: abrasive, fragile, sticky or agglomerated.\n\n\n Morphological Analysis\n\n \n\t The description of the specific composition of the particle mixture.\n\t Identify particles by morphologically oriented Raman spectroscopy.\n\t Control the particle size and shape of API and excipients during the development process and throughout the formulation and processing process.\n\t Simplify the modification challenge of generic drugs to support in vitro bioequivalence.\n\t Detect abnormalities and contaminants during the manufacturing process and identify process deviations.\n\n\n Surface Area